Workflow
上海皓元医药股份有限公司关于调整可转换公司债券“皓元转债”转股价格的公告
688131Chemexpress(688131) 上海证券报· Shang Hai Zheng Quan Bao·2025-05-06 21:49

Core Viewpoint - The company announced an adjustment to the conversion price of its convertible bonds "Haoyuan Convertible Bonds" from RMB 40.73 per share to RMB 40.58 per share, effective from May 14, 2025, due to the distribution of cash dividends [2][7][11]. Summary by Sections Convertible Bond Details - The company issued RMB 822.35 million of convertible bonds with a maturity of 6 years, and the initial conversion price was set at RMB 40.73 per share [2]. - The conversion period for the bonds is from June 4, 2025, to November 27, 2030 [2]. Adjustment Basis - The adjustment of the conversion price was approved during the board meeting on March 26, 2025, and the annual general meeting on April 18, 2025 [3]. - The total share capital for the dividend distribution was 210,959,781 shares, with 47,725 shares excluded due to performance compensation, resulting in 210,912,056 shares participating in the distribution [4]. Dividend Distribution - The company will distribute a cash dividend of RMB 1.50 per 10 shares, totaling RMB 31,636,808.40 (including tax) [4][17]. - The ex-dividend date is set for May 14, 2025, with the record date being May 13, 2025 [4][10]. Conversion Price Adjustment Method - The conversion price adjustment formula used was P1 = P0 - D, where P0 is the previous conversion price, and D is the cash dividend per share [8][11]. - The adjusted conversion price is calculated as follows: P1 = 40.73 - 0.14997 = 40.58 [11]. Other Information - The company will follow the regulations outlined in the prospectus regarding any future adjustments to the conversion price due to stock dividends, capital increases, or other equity changes [5][9].